Related Experiment Video

Updated: Feb 22, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K

The importance of bone biopsy in chronic kidney disease-Mineral bone disorders

Periklis Dousdampanis1, Kostantina Trigka1

  • 1Hemodialysis Unit Kyanos Stavros, Patras, Greece.

Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia
|September 23, 2017
PubMed

Insights

Renal osteodystrophy (ROD), now termed CKD-mineral and bone disorder (CKD-MBD), requires precise diagnosis. Bone biopsy is ideal but impractical, necessitating research into specific biomarkers for better management of bone disease in chronic kidney disease patients.

Area of Science:

  • Nephrology
  • Endocrinology
  • Bone Metabolism

Background:

  • Renal osteodystrophy (ROD) is a complex group of bone diseases stemming from chronic kidney disease (CKD).
  • The term CKD-mineral and bone disorder (CKD-MBD) encompasses a broader spectrum than traditional ROD.
  • Current biomarkers like parathyroid hormone (PTH) and alkaline phosphatase may not accurately reflect bone turnover in CKD-MBD.

Purpose of the Study:

  • To highlight the limitations of current diagnostic methods for CKD-MBD.
  • To emphasize the diagnostic value of bone biopsy despite its clinical limitations.
  • To advocate for the development of specific biomarkers for CKD-MBD.

Main Methods:

  • Review of existing literature on ROD and CKD-MBD.
  • Analysis of the diagnostic utility of bone biopsy versus non-invasive markers.
  • Discussion of the challenges and potential future directions for biomarker research.

Main Results:

  • Bone biopsy offers precise histopathological information crucial for diagnosing CKD-MBD.
  • Non-invasive biomarkers and tools often lack the specificity required for accurate diagnosis.
  • Clinical application of bone biopsy is limited due to invasiveness and lack of nephrologist training.

Conclusions:

  • Accurate diagnosis of CKD-MBD is essential for effective therapeutic strategies.
  • The impracticality of bone biopsy necessitates the urgent study of novel, specific biomarkers.
  • Developing reliable biomarkers is key to improving the management of bone disease in CKD.

More Related Videos

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

2.6K
Using a Chemical Biopsy for Graft Quality Assessment05:00

Using a Chemical Biopsy for Graft Quality Assessment

Published on: June 17, 2020

5.7K

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
503
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
827
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
758
What is the Skeletal System?01:02

What is the Skeletal System?

Overview
57.9K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
363
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
444